These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 31423748

  • 1. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
    Hinrichs GR, Weyer K, Friis UG, Svenningsen P, Lund IK, Nielsen R, Mollet G, Antignac C, Bistrup C, Jensen BL, Birn H.
    Acta Physiol (Oxf); 2019 Dec; 227(4):e13362. PubMed ID: 31423748
    [Abstract] [Full Text] [Related]

  • 2. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M, Buhl KB, Andersen RF, Svenningsen P, Nielsen F, Hinrichs GR, Bistrup C, Jensen BL.
    Am J Physiol Renal Physiol; 2015 Aug 01; 309(3):F235-41. PubMed ID: 25972510
    [Abstract] [Full Text] [Related]

  • 3. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
    Bohnert BN, Daiminger S, Wörn M, Sure F, Staudner T, Ilyaskin AV, Batbouta F, Janessa A, Schneider JC, Essigke D, Kanse S, Haerteis S, Korbmacher C, Artunc F.
    Acta Physiol (Oxf); 2019 Dec 01; 227(4):e13286. PubMed ID: 31006168
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome.
    Larionov A, Dahlke E, Kunke M, Zanon Rodriguez L, Schiessl IM, Magnin JL, Kern U, Alli AA, Mollet G, Schilling O, Castrop H, Theilig F.
    J Cell Mol Med; 2019 Oct 01; 23(10):6543-6553. PubMed ID: 31368174
    [Abstract] [Full Text] [Related]

  • 6. Plasmin in nephrotic urine activates the epithelial sodium channel.
    Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skøtt O.
    J Am Soc Nephrol; 2009 Feb 01; 20(2):299-310. PubMed ID: 19073825
    [Abstract] [Full Text] [Related]

  • 7. Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.
    Andersen H, Friis UG, Hansen PB, Svenningsen P, Henriksen JE, Jensen BL.
    Nephrol Dial Transplant; 2015 May 01; 30(5):781-9. PubMed ID: 25609736
    [Abstract] [Full Text] [Related]

  • 8. Amiloride: the "new" renal tonic?
    Warnock DG.
    Am J Physiol Renal Physiol; 2015 Sep 01; 309(5):F429-30. PubMed ID: 26084931
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome.
    Xiao M, Bohnert BN, Aypek H, Kretz O, Grahammer F, Aukschun U, Wörn M, Janessa A, Essigke D, Daniel C, Amann K, Huber TB, Plow EF, Birkenfeld AL, Artunc F.
    Acta Physiol (Oxf); 2021 Jan 01; 231(1):e13512. PubMed ID: 32455507
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanisms of sodium retention in nephrotic syndrome.
    Hinrichs GR, Jensen BL, Svenningsen P.
    Curr Opin Nephrol Hypertens; 2020 Mar 01; 29(2):207-212. PubMed ID: 31789848
    [Abstract] [Full Text] [Related]

  • 14. Proteinuric diseases with sodium retention: Is plasmin the link?
    Svenningsen P, Skøtt O, Jensen BL.
    Clin Exp Pharmacol Physiol; 2012 Jan 01; 39(1):117-24. PubMed ID: 21466573
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Albuminuria in kidney transplant recipients is associated with increased urinary serine proteases and activation of the epithelial sodium channel.
    Hinrichs GR, Michelsen JS, Zachar R, Friis UG, Svenningsen P, Birn H, Bistrup C, Jensen BL.
    Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F151-F160. PubMed ID: 29363322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of Urinary Plasminogen-Plasmin with Edema and Epithelial Sodium Channel Activation in Patients with Nephrotic Syndrome.
    Chen JL, Wang L, Yao XM, Zang YJ, Wang Y, Li ZJ, Pearce D, Wang H.
    Am J Nephrol; 2019 Jul 01; 50(2):92-104. PubMed ID: 31269481
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.